Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

NCT05860400 · clinicaltrials.gov ↗

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Artery Stenosis
Coronary Artery Restenosis
Coronary Artery Disease Progression
Inflammation
Inflammatory Disease
Inflammation Vascular

Interventions

BEHAVIORAL: Healthy life style
DRUG: Secondary prevention for atherosclerotic coronary artery disease
DRUG: Immunosuppressive therapy
PROCEDURE: Coronary revascularization
DRUG: Supportive therapies

Sponsor

Peking Union Medical College Hospital